Relationship between markers of HIV-1 disease progression and serum β-carotene concentrations in Kenyan women

International Journal of STD and AIDS

Volumn 18, Issue 3, 2007, Pages 202-206

  Baeten, Jared M ^a   McClelland, R Scott ^a   Wener, Mark H ^a   Bankson, Daniel D ^a,b   Lavreys, Ludo ^a   Mandaliya, Kishorchandra ^c   Bwayo, Job J ^d   Kreiss, Joan K ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c Department of Obstetrics and Gynaecology   (Kenya)

^d UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

carotene; Acute phase response; HIV 1; Micronutrient deficiency; Nutritional assessment; Nutritional status; Vitamin A

Indexed keywords

ALBUMIN; BETA CAROTENE; C REACTIVE PROTEIN; RETINOL;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VIRUS LOAD; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WOMEN'S HEALTH; BLOOD; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CROSS-SECTIONAL STUDY; GROWTH, DEVELOPMENT AND AGING; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; METABOLISM; RANDOMIZED CONTROLLED TRIAL; VIROLOGY;

ADULT; BETA CAROTENE; C-REACTIVE PROTEIN; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; KENYA; VIRAL LOAD; VITAMIN A;

EID: 34547582050     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646207780132541     Document Type: Article

References (31)

1. UNAIDS/WHO. AIDS Epidemic Update: December 2004. Available at: [www.unaids.org/wad2004/EPI_1204_pdf_en/EpiUpdate04_en.pdf.] Last accessed 30 December 2004
2. Fawzi WW, Hunter DJ. Vitamins and HIV disease progression and vertical transmission. Epidemiology 1998;9:457-66
3. Nimmagadda A, O'Brien WA, Goetz MB. The significance of vitamin A and carotenoid status in persons infected by the human immunodeficiency virus. Clin Infect Dis 1998;26:711-18
4. Sappey C, Leclercq P, Coudray C, Faure P, Micoud M, Favier A. Vitamin, trace element and peroxide status in HIV seropositive patients: asymptomatic patients present a severe beta-carotene deficiency. Clin Chim Acta 1994;230:35-42
5. Phuapradit W, Chaturachinda K, Taneepanichskul S, Sirivarasry J, Khupulsup K, Lerdvuthisopon N. Serum vitamin A and beta-carotene levels in pregnant women infected with human immunodeficiency virus-1. Obstet Gynecol 1996;87:564-7
6. Coodley GO, Coodley MK, Lusk R, et al. Beta-carotene in HIV infection: an extended evaluation. AIDS 1996;10:967-73
7. Friis H, Gomo E, Koestel P, et al. HIV and other predictors of serum beta-carotene and retinol in pregnancy: a cross-sectional study in Zimbabwe. Am J Clin Nutr 2001;73:1058-65
8. Bendich A. Beta-carotene and the immune response. Proc Nutr Soc 1991;50:263-74
9. Allard JP, Aghdassi E, Chau J, Salit I, Walmsley S. Oxidative stress and plasma antioxidant micronutrients in humans with HIV infection. Am J Clin Nutr 1998;67:143-7
10. Fawzi WW, Msamanga GI, Spiegelman D, et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet 1998;351:1477-82
11. Nimmagadda AP, Burri BJ, Neidlinger T, O'Brien WA, Goetz MB. Effect of oral beta-carotene supplementation on plasma human immunodeficiency virus (HIV) RNA levels and CD4+ cell counts in HIV-infected patients. Clin Infect Dis 1998;27:1311-13
12. Constans J, Delmas-Beauvieux MC, Sergeant C, et al. One-year antioxidant supplementation with beta-carotene or selenium for patients infected with human immunodeficiency virus: a pilot study. Clin Infect Dis 1996;23:654-6
13. Fawzi WW, Msamanga GI, Spiegelman D, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med 2004;351:23-32
14. Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. The South African Vitamin A Study Group. AIDS 1999;13:1517-24
15. Fawzi WW, Msamanga GI, Hunter D, et al. Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. AIDS 2002;16:1935-44
16. Baeten JM, McClelland RS, Overbaugh J, et al. Vitamin A supplementation and HIV-1 shedding in women: results of a randomized clinical trial. J Infect Dis 2002;185:1187-91
17. Baeten JM, McClelland RS, Richardson BA, et al. Vitamin A deficiency and the acute phase response among HIV-1 infected and uninfected women in Kenya. J Acquir Immune Defic Syndr 2002;31:234-9
18. DeVange Panteleeff D, Emery S, Richardson BA, et al. Validation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples. J Clin Microbiol 2002;40:3929-37
19. Epler KS, Ziegler RG, Craft NE. Liquid chromatographic method for the determination of carotenoids, retinoids and tocopherols in human serum and in food. J Chromatogr 1993;619:37-48
20. Feldman JG, Goldwasser P, Holman S, DeHovitz J, Minkoff H. C-reactive protein is an independent predictor of mortality in women with HIV-1 infection. J Acquir Immune Defic Syndr 2003;32:210-14
21. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-54
22. Stephensen CB, Gildengorin G. Serum retinol, the acute phase response, and the apparent misclassification of vitamin A status in the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2000;72:1170-8
23. Paracha PI, Jamil A, Northrop-Clewes CA, Thurnham DI. Interpretation of vitamin A status in apparently healthy Pakistani children by using markers of subclinical infection. Am J Clin Nutr 2000;72:1164-9
24. Dati F, Schumann G, Thomas L, et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470) International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists Eur J Clin Chem Clin Biochem 1996;34:517-20
25. Feldman JG, Burns DN, Gange SJ, et al. Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV study. AIDS 2000;14:863-70
26. Fawzi WW, Msamanga G, Hunter D, et al. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. J Acquir Immune Defic Syndr 2000;23:246-54
27. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-35
28. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9
29. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5
30. Erlinger TP, Guallar E, Miller III ER, Stolzenberg-Solomon R, Appel LJ. Relationship between systemic markers of inflammation and serum beta-carotene levels. Arch Intern Med 2001;161:1903-8
31. Lakshman MR, Rao MN. Purification and characterization of cellular carotenoid-binding protein from mammalian liver. Methods Enzymol 1999;299:441-56